Showing 1-7 of 7

Sorted By:

  • Breast Cancer: Alliance A011401 (Iowa Cancer Specialists)

    This study is being done to see if losing weight may help prevent breast cancer from coming back (recurring).

  • Breast Cancer: Alliance A011502 (ABC Study)

    The purpose of this study is to compare any good and bad effects of using aspirin after someone has completed the usual chemotherapy, surgery and/or radiation therapy for breast cancer.

  • Breast Cancer: Breast Cancer Collaborative Registry

    This registry/tissue bank is focused on the collection of detailed information and biological samples on participants to help create a resource that will be helpful to researchers in future studies related to breast cancer.

  • Breast Cancer: EA1131 (Iowa Cancer Specialists)

    The purpose of this study is to compare getting more treatment with capecitabine (i.e. one of the usual approaches), to any good and bad effects of getting more treatment with a platinum-based chemotherapy (cisplatin or carboplatin), after surgery for patients with triple-negative breast cancer.

  • Breast Cancer: NRG-BR003 (Iowa Cancer Specialists)

    The purpose of this study is to compare the good and bad effects of the chemotherapy drug, carboplatin, given with the usual chemotherapy drugs after surgery, compared to the usual chemotherapy drugs given without carboplatin.

  • Breast Cancer: S1416 (Iowa Cancer Specialists)

    The main purpose of this study is to compare any good and bad effects of using ABT-888 (Veliparib) (a “PARP” inhibitor) along with cisplatin to using cisplatin alone.

  • Breast Cancer: S1418/BR006

    The purpose of this study is to compare the usual approach (i.e. no more treatment or additional post-operative chemotherapy), to any effects, good and/or bad, of the experimental drug MK-3475 (also called pembrolizumab) after surgery.

Page InfoPage
Showing trials 1-7 of 7

View Additional Section Content

Contact Us

For more information about our research program and IRB, please contact:

Research Support Office
563-421-7955

Email